The susceptibility of Aire-/- mice to experimental myasthenia gravis involves alterations in regulatory T cells

Journal of Autoimmunity

Volumn 36, Issue 1, 2011, Pages 16-24

  Aricha, Revital ^a   Feferman, Tali ^a   Scott, Hamish S ^b   Souroujon, Miriam C ^a,c   Berrih Aknin, Sonia ^d   Fuchs, Sara ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c OPEN UNIVERSITY OF ISRAEL   (Israel)

^d Sorbonne Université   (France)

Author keywords

Aire; Experimental autoimmune myasthenia gravis (EAMG); Regulatory T cells; Spleen; Thymus

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; CHOLINERGIC RECEPTOR; KI 67 ANTIGEN; L SELECTIN; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; IMMUNOPATHOGENESIS; MOUSE; MOUSE STRAIN; MYASTHENIA GRAVIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; THYMUS; WILD TYPE;

AGE FACTORS; ANIMALS; CELL SEPARATION; DISEASE SUSCEPTIBILITY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; RECEPTORS, CHOLINERGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 79151482847     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.09.007     Document Type: Article

References (49)

1. Nomura T., Sakaguchi S. Foxp3 and Aire in thymus-generated Treg cells: a link in self-tolerance. Nat Immunol 2007, 8:333-334.
2. Peterson P., Org T., Rebane A. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol 2008, 8:948-957.
3. Gardner J.M., Devoss J.J., Friedman R.S., Wong D.J., Tan Y.X., Zhou X., et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 2008, 321:843-847.
4. Hubert F.X., Kinkel S.A., Webster K.E., Cannon P., Crewther P.E., Proeitto A.I., et al. A specific anti-Aire antibody reveals Aire expression is restricted to medullary thymic epithelial cells and not expressed in periphery. J Immunol 2008, 180:3824-3832.
5. Kekalainen E., Tuovinen H., Joensuu J., Gylling M., Franssila R., Pontynen N., et al. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol 2007, 178:1208-1215.
6. Anderson M.S., Venanzi E.S., Chen Z., Berzins S.P., Benoist C., Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity 2005, 23:227-239.
7. Kuroda N., Mitani T., Takeda N., Ishimaru N., Arakaki R., Hayashi Y., et al. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol 2005, 174:1862-1870.
8. Conti-Fine B.M., Milani M., Kaminski H.J. Myasthenia gravis: past, present, and future. J Clin Invest 2006, 116:2843-2854.
9. Christadoss P., Poussin M., Deng C. Animal models of myasthenia gravis. Clin Immunol 2000, 94:75-87.
10. Bai Y., Liu R., Huang D., La Cava A., Tang Y.Y., Iwakura Y., et al. CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity. Eur J Immunol 2008, 38:1877-1888.
11. Mu L., Sun B., Kong Q., Wang J., Wang G., Zhang S., et al. Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis. Immunology 2009, 128:e826-e836.
12. Masuda M, Matsumoto M, Tanaka S, Nakajima K, Yamada N, Ido N et al. Clinical implication of peripheral CD4(+)CD25(+) regulatory T cells and Th17 cells in myasthenia gravis patients. J Neuroimmunol.
13. Balandina A., Lecart S., Dartevelle P., Saoudi A., Berrih-Aknin S. Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005, 105:735-741.
14. Fattorossi A., Battaglia A., Buzzonetti A., Ciaraffa F., Scambia G., Evoli A. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology 2005, 116:134-141.
15. Sun Y., Qiao J., Lu C.Z., Zhao C.B., Zhu X.M., Xiao B.G. Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy. Clin Immunol 2004, 112:284-289.
16. Aricha R., Feferman T., Fuchs S., Souroujon M.C. Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis. J Immunol 2008, 180:2132-2139.
17. Scarpino S., Di Napoli A., Stoppacciaro A., Antonelli M., Pilozzi E., Chiarle R., et al. Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas. Clin Exp Immunol 2007, 149:504-512.
18. Giraud M., Taubert R., Vandiedonck C., Ke X., Levi-Strauss M., Pagani F., et al. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature 2007, 448:934-937.
19. Marx A., Willcox N., Leite M.I., Chuang W.Y., Schalke B., Nix W., et al. Thymoma and paraneoplastic myasthenia gravis. Autoimmunity 2010, 43:413-427.
20. Campbell I.K., Kinkel S.A., Drake S.F., van Nieuwenhuijze A., Hubert F.X., Tarlinton D.M., et al. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis. Arthritis Rheum 2009, 60:1683-1693.
21. Hubert F.X., Kinkel S.A., Crewther P.E., Cannon P.Z., Webster K.E., Link M., et al. Aire-deficient C57BL/6 mice mimicking the common human 13-base pair deletion mutation present with only a mild autoimmune phenotype. J Immunol 2009, 182:3902-3918.
22. Kedzierska K., Valkenburg S.A., Guillonneau C., Hubert F.X., Cukalac T., Curtis J.M., et al. Diversity and clonotypic composition of influenza-specific CD8(+) TCR repertoires remain unaltered in the absence of Aire. Eur J Immunol 2009.
23. Kont V., Laan M., Kisand K., Merits A., Scott H.S., Peterson P. Modulation of Aire regulates the expression of tissue-restricted antigens. Mol Immunol 2008, 45:25-33.
24. Fuchs S., Nevo D., Tarrab-Hazdai R., Yaar I. Strain differences in the autoimmune response of mice to acetylcholine receptors. Nature 1976, 263:329-330.
25. Sheng J.R., Li L.C., Ganesh B.B., Prabhakar B.S., Meriggioli M.N. Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis. Clin Immunol 2008, 128:172-180.
26. Aharonov A., Tarrab-Hazdai R., Silman I., Fuchs S. Immunochemical studies on acetylcholine receptor from Torpedo californica. Immunochemistry 1977, 14:129-137.
27. Feferman T., Aricha R., Mizrachi K., Geron E., Alon R., Souroujon M.C., et al. Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3. J Neuroimmunol 2009, 209:87-95.
28. Berman P.W., Patrick J. Experimental myasthenia gravis. a murine system. J Exp Med 1980, 151:204-223.
29. Cheng M.H., Shum A.K., Anderson M.S. What's new in the Aire?. Trends Immunol 2007, 28:321-327.
30. De Ravin S.S., Cowen E.W., Zarember K.A., Whiting-Theobald N.L., Kuhns D.B., Sandler N.G., et al. Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood 2010, 116:1263-1271.
31. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., et al. Projection of an immunological self shadow within the thymus by the Aire protein. Science 2002, 298:1395-1401.
32. Ramsey C., Winqvist O., Puhakka L., Halonen M., Moro A., Kampe O., et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 2002, 11:397-409.
33. Liston A., Lesage S., Wilson J., Peltonen L., Goodnow C.C. Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003, 4:350-354.
34. Chen Z., Benoist C., Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci U S A 2005, 102:14735-14740.
35. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
36. Aschenbrenner K., D'Cruz L.M., Vollmann E.H., Hinterberger M., Emmerich J., Swee L.K., et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 2007, 8:351-358.
37. Hinterberger M, Aichinger M, da Costa OP, Voehringer D, Hoffmann R, Klein L. Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat Immunol;11: 512-519.
38. Wolff A.S., Oftedal B.E., Kisand K., Ersvaer E., Lima K., Husebye E.S. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scand J Immunol 2010, 71:459-467.
39. Laakso S.M., Laurinolli T.T., Rossi L.H., Lehtoviita A., Sairanen H., Perheentupa J., et al. Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population. J Autoimmun 2010, Aug 28.
40. Weaver C.T., Murphy K.M. The central role of the Th17 lineage in regulating the inflammatory/autoimmune axis. Semin Immunol 2007, 19:351-352.
41. Korn T., Oukka M., Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 2007.
42. Ivanov S., Bozinovski S., Bossios A., Valadi H., Vlahos R., Malmhall C., et al. Functional relevance of the IL-23-IL-17 axis in lungs in vivo. Am J Respir Cell Mol Biol 2007, 36:442-451.
43. Eberl G., Littman D.R. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 2004, 305:248-251.
44. Shibata K., Yamada H., Nakamura R., Sun X., Itsumi M., Yoshikai Y. Identification of CD25+ gamma delta T cells as fetal thymus-derived naturally occurring IL-17 producers. J Immunol 2008, 181:5940-5947.
45. Romagnani S., Maggi E., Liotta F., Cosmi L., Annunziato F. Properties and origin of human Th17 cells. Mol Immunol 2009.
46. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
47. Prelog M., Keller M., Geiger R., Brandstatter A., Wurzner R., Schweigmann U., et al. Thymectomy in early childhood: significant alterations of the CD4(+)CD45RA(+)CD62L(+) T cell compartment in later life. Clin Immunol 2009, 130:123-132.
48. Hassler S., Ramsey C., Karlsson M.C., Larsson D., Herrmann B., Rozell B., et al. Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma. Blood 2006, 108:1941-1948.
49. Fan Y., Rudert W.A., Grupillo M., He J., Sisino G., Trucco M. Thymus-specific deletion of insulin induces autoimmune diabetes. Embo J 2009, 28:2812-2824.